Cortisone retards the initiation of mesenchymal reaction after injury.' We have shown that new capillaries do not proliferate, that reticulin is not elaborated, and that the fibroblasts seem supressed. On the other hand, epithelization occurs, although its rate is somewhat slowed. These changes occur regardless of whether cortisone is administered generally or locally.
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Transplantation of tumors succeeds if the "stromal reaction" occurs and the transplanted tissue is able to acquire a new blood supply. This stromal reaction is a mesenchymal proliferation and likewise should be repressed by cortisone. It has been studied by many and has been summarized by Woglom,B as follows:
The first evidence of reaction to the graft was a rapid aggregation of polymorphonuclear leucocytes in the surrounding tissues of the host, beginning about two hours after the introduction of the tumor fragment and of short duration only. The leucocytes collected about any necrotic material present and even penetrated between the tumor cells. About fifteen hours after the introduction of the graft there occurred proliferative changes in surrounding areolar connective tissue of the host, the cells of which became shorter and thicker, while their nuclei divided by amitosis. The proliferating cells migrated into the cleft which originally separated the connective tissue of the host from the newly introduced fragment, and applied themselves to the surface of the graft. The stroma had already become hyaline after twenty-four hours, and commencing degeneration could often be detected in its cells. Such changes were even more distinct after thirty-six hours.... The capillaries of the graft with their blood corpuscles were still recognizable, although the endothelium showed degenerative changes. Outside of the graft fibrin filaments had appeared in the exudate and amitotic division of the connective tissue cells was still in progress, while spindle-shaped wandering cells had begun to penetrate the transplanted tumor. Three days after inoculation the cleft between the tumor and the host's tissues was almost obliterated, and wandering cells could be distinguished in the interstices of the graft, where they were dividing by mitosis. Mitotic division was in evidence, also, in the fibroblasts of the host nearest the tumor. . . . No development of new blood vessels had yet occurred and the whole mass of transplanted tissue remained without vascular supply. Four days after transplantation, however, an ingrowth of capillaries had taken place and vascularization was in such rapid progress that all stages of new capillary formation might be found in the same specimen. Fibroblasts from the host were streaming into the tumor from every side, some of them appearing to exercise a phagocytic function and finally to degenerate, while others survived to form the new stroma. The old connective tissue still remained, but was in the last stages of degeneration. From four days onward there was a continual recession of the stroma originally introduced, and an orderly progress of vascularization until, by the eleventh day, fibrils of new-formed collagen could be found in the new stroma which, at the eighth, had been very cellular. If cortisone retards the stromal reaction, theoretically even autogenous transplantations should be less successful under the influence of cortisone.
On To determine whether cortisone will aid or hinder the transplantation of tumors, the following investigation was carried out. Whitelaw7 believes that he has grafted normal skin homologously under the influence of ACTH. The one clinical trial cited is undocumented and uncontrolled. Sugiura, Stock, Dobriner, and Rhoads have tested the influence of cortisone on growth of tumors already transplanted.' Methods Two methods were employed to test the influence of cortisone on homologously transplanted tumors. In the first method, cortisone was given to the Rockland Swiss white mice that are relatively resistant to the transplantation of tumors E0771 and 775. These adenocarcinomata are usually transplanted and grow successfully in the C57 black mice. Cortisone was given parenterally to the white mice in doses varying from 0.005 mg./gm. to 0.01 mg./gm. starting two days before to ten days after transplantation of the tumors from the black mice. With both tumors cortisone was also implanted locally at the time of transplantation. Semi-solid cortisone was obtained by centrifuging its suspension, and a very small amount was placed on the transplant by dipping the end of a probe into the residue and wiping it on the transplant. In the first experiments, one transplant was placed on each side of the abdomen of one mouse and both tumors were treated with cortisone. Later, only one transplant was treated in each animal, keeping the other side for a control. Special care was employed to be certain that cortisone did not contaminate the instruments used to transplant the untreated tumor.
In the second method, tumors were produced in white Wistar rats by means of methylcholanthrene incorporated in transplanted stomach mucosa. Most of these tumors took a year or more to develop. When they were first transplanted in the Wistar rats, half of the rats were treated with cortisone while the other half were not. The type of tumor transplanted is indicated in Table 3 as well as the information indicating whether the transplantation was the initial or the second sub-transplantation. Cortisone was given parenterally, 30 mg./kg., to some of these animals while it was implanted locally with the tumor in others.
With both methods, the tumor growths were measured on the seventh, ninth, and fourteenth days. Gross examination was made of all tumors to observe the extent of necrosis and the degree of encapsulation. Sections were taken from each tumor for microscopic examination.
The mice and rats were fed on a standard laboratory diet before and throughout the experiment. Some initial testing had to be done to find the dose of cortisone that would not kill the animal and yet be large enough to disturb allergenic reactions and the regeneration of the mesenchyme.
Results
Cortisone, given parenterally and implanted locally, definitely increased the number of successful homologous transplantations of the adenocarcinomata transferred to a new strain of animals in which they ordinarily did not take. The percentage increase of successful takes was greater for tumor E0771, which normally showed a higher incidence of success with homo-logous transplantation, than for tumor 755 (Table 1 Parenterally administered cortisone doubled the number of successful homologous transplantations of methylcholanthrene-induced tumors in the rat even though they were largely of mesenchymal origin. These induced tumors took in 56%o of the rats given cortisone, whereas only 11%o took when no cortisone was given (Table 3) .
In a smaller group of rats, the transfer of methylcholanthrene-induced tumors was made from August Tan and White rats to Wistars. For this group, the incidence of successful transplants rose in the Wistars from 0 to 22%o under the influence of cortisone (Table 4) . Eighty per cent of the transplants took when the inbred strain of August Tan and White rats was used for the first transplantation when no cortisone was used. This figure is much higher than for the commercial Wistar to Wistar transplantation without cortisone; with these only 11%o took.
All transplants growing under the influence of cortisone grew poorly as compared to those growing in the susceptible hosts.
Gross and microscopic examination showed that the E0771 and 775 tumors, successfully transplanted into the Swiss mice under the influence of cortisone, developed a new blood supply. Grossly, many blood vessels, particularly veins, were seen over the surface of the tumors. Microscopically, the blood supply seemed to be more at the periphery of the tumor than Discussion No statistical analysis has been made of the results, for it is realized that the ultimate answer about the influence of cortisone on the transplantation of tumors can only be had by transferring many types of tumors in different animals. The results will certainly be affected by the cell composition of the tumors, the difference in susceptibility of the species to cortisone, and the capacity of the tumor for homologous transplantation before cortisone is given. The work suggests that cortisone enhances the tendency for homologous transplantation when the host is not too resistant.
Apparently, the stromal reaction was not inhibited by the presence of cortisone. Lymph nodes and lymphocytes were seen but they were more abundant in the 755 tumors where the percentage of successful transplants was smaller.
It is surprising that cortisone increased the number of successful transplantations of methylcholanthrene-induced tumors, largely of mesenchymal origin. Our previous experiments showed' that cortisone inhibits the initiation of mesenchymal proliferation, while the growth of fibrosarcomas, clinically, has not been arrested by the administration of cortisone.8 However, experimentally, inhibition of growth depended on the type of tumor; some sarcomas were affected, others were not.' Diminution of awareness of the host to the presence of the growth of a slightly foreign cell seems to be the best answer for the increased yield of homologous tumor transplants. The employment of cortisone ought to be useful to propagate the tumors needed in the study of cancer chemotherapy.
Conclusions
Parenteral administration of cortisone seems to improve the possibility of homologous transplantation of tumors, particularly if the tumor shows some tendency toward homologous transplantation. Diminution of awareness of the host is offered as a possible explanation.
